FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -97.8% | 376 | -97.6% | 0.00% | – |
| Q1 2023 | $45 | -66.9% | 15,843 | -15.1% | 0.00% | – |
| Q4 2022 | $136 | -99.9% | 18,664 | +0.0% | 0.00% | – |
| Q3 2022 | $151,000 | +65.9% | 18,660 | +0.6% | 0.00% | – |
| Q2 2022 | $91,000 | -79.3% | 18,555 | -0.2% | 0.00% | – |
| Q1 2022 | $440,000 | +33.7% | 18,601 | +0.1% | 0.00% | – |
| Q4 2021 | $329,000 | -37.3% | 18,585 | -0.1% | 0.00% | -100.0% |
| Q3 2021 | $525,000 | +303.8% | 18,598 | +49.9% | 0.00% | – |
| Q2 2021 | $130,000 | -10.3% | 12,410 | +1.2% | 0.00% | – |
| Q1 2021 | $145,000 | +0.7% | 12,267 | 0.0% | 0.00% | – |
| Q4 2020 | $144,000 | +48.5% | 12,267 | 0.0% | 0.00% | – |
| Q3 2020 | $97,000 | -56.7% | 12,267 | 0.0% | 0.00% | – |
| Q2 2020 | $224,000 | +224.6% | 12,267 | +112.7% | 0.00% | – |
| Q1 2020 | $69,000 | -28.1% | 5,767 | 0.0% | 0.00% | – |
| Q4 2019 | $96,000 | +152.6% | 5,767 | 0.0% | 0.00% | – |
| Q3 2019 | $38,000 | – | 5,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |